Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Huang, Bing S ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Aldosterone; Cardiac dysfunction; Myocardial infarction

Indexed keywords

ALDOSTERONE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BENZAMIL; BRAIN RECEPTOR; GUANABENZ; MINERALOCORTICOID RECEPTOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; RECEPTOR BLOCKING AGENT; SODIUM CHANNEL; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG EFFICACY; EPITHELIUM; EVALUATION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; KIDNEY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSMOTIC MINIPUMP; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; RAT STRAIN; SYMPATHETIC TONE;

ALDOSTERONE ANTAGONISTS; AMILORIDE; ANIMALS; BAROREFLEX; BLOOD PRESSURE; EPITHELIAL SODIUM CHANNEL; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; RECEPTORS, MINERALOCORTICOID; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SPIRONOLACTONE; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR FUNCTION, LEFT;

EID: 18044389350     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00840.2004     Document Type: Article

References (44)

1. Amin MS and Leenen FHH. Mineralocorticoid receptor and epithelial sodium channel expression in the brain (Abstract). Can J Cardiol 20, Suppl D: 57D, 2004.
2. Betz AL, Keep RF, Beer ME, and Ren XD. Blood-brain barrier permeability and brain concentration of sodium, potassium, and chloride during focal ischemia. J Cereb Blood Flow Metab 14: 29-37, 1994.
3. Blazer-Yost BL, Esterman MA, and Vlahos CJ. Insulin-stimulated trafficking of ENaC in renal cells requires PI 3-kinase activity. Am J Physiol Cell Physiol 284: C1645-C1653, 2003.
4. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, and Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97: 1382-1391, 1998.
5. Brilla CG. Aldosterone and myocardial fibrosis in heart failure. Herz 25: 299-306, 2000.
6. Davson H and Segal MB. The secretion of cerebrospinal fluid. In: Physiology of the Cerebrospinal Fluid and Blood Brain Barriers. Boca Raton, FL: CRC; 1996, p. 194-255.
7. DiBona GF, Jones SY, and Brooks VL. ANG II receptor blockade and arterial baroreflex regulation of renal sympathetic nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physlol 269: R1189-R1196, 1995.
8. Flesch M, Hoper A, Dell'Italia L, Evans K, Bond R, Peshock R, Diwan A, Brinsa TA, Wei CC, Sivasubramanian N, Spinale FG, and Mann DL. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 108: 598-604, 2003.
9. Francis J, Chu Y, Johnson AK, Weiss RM, and Felder RB. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol Heart Circ Physiol 286: H2264-H2271, 2004.
10. Francis J, Wei SG, Weiss RM, and Felder RB. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am J Physiol Heart Circ Physiol 287: H2138-H2146, 2004.
11. Francis J, Weiss RM, Johnson AK, and Felder RB. Central mineralocorticoid receptor blockade decreases plasma TNF-α after coronary artery ligation in rats. Am J Physiol Regul Integr Comp Physiol 284: R328-R335, 2003.
12. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, and Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281: H2241-H2251, 2001.
13. + channels. FASEB J 8: 522-528, 1994.
14. Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118: 819-823, 1986.
15. Gomez-Sanchez EP, Fort C, and Thwaites D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol Endocrinol Metab 262: E96-E99, 1992.
16. Gomez-Sanchez EP and Gomez-Sanchez CE. Effect of central infusion of benzamil on Dahl S rat hypertension. Am J Physiol Heart Circ Physiol 269: H1044-H1047, 1995.
17. Gomez-Sanchez EP, Samuel J, Vergara G, and Ahmad N. Effect of 3β-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat. Am J Physiol Regul Integr Comp Physiol 288: R389-R393, 2005.
18. Huang BS, Harmsen E, Yu H, and Leenen FHH. Brain ouabain-like activity and the sympathoexcitatory and pressor effects of central sodium in rats. Circ Res 71: 1059-1066, 1992.
19. Huang BS and Leenen FHH. Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake. Hypertension 32: 1028-1033, 1998.
20. +] precede the increases in blood pressure in Dahl S rats and SHR on high salt intake. Am J Physiol Heart Circ Physiol 287: H1160-H1166, 2004.
21. +], pH, and volume. Am J Physiol Renal Fluid Electrolyte Physiol 258: F1538-F1546, 1990.
22. Kageyama Y, Suzuki H, and Saruta T. Presence of aldosterone-like immunoreactivity in cerebrospinal fluid in normotensive subjects. Acta Endocrinol 126: 501-504, 1992.
23. +-ATPase activity, increase in potassium uptake, and enhanced production of ouabain-like compounds in ammonia-treated mouse astrocytes. Neurochem Int 36: 203-211, 2000.
24. Lal A, Veinot JP, and Leenen FHH. Critical role of CNS effects of aldosterone in cardiac remodeling post myocardial infarction in rats. Cardiovasc Res 64: 437-447, 2004.
25. Leenen FHH, Huang BS, Yu H, and Yuan B. Brain "ouabain" mediates sympathetic hyperactivity in congestive heart failure. Circ Res 77: 993-1000, 1995.
26. Leenen FHH, Skarda V, Yuan B, and White R. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am J Physiol Heart Circ Physiol 276: H317-H325, 1999.
27. Lindley TE, Doobay MF, Sharma RV, and Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res 94: 402-409, 2004.
28. Machida K, Nonoguchi H, Wakamatsu S, Inoue H, Yoshifovska T, Inoue T, and Tomita K. Acute regulation of the epithelial sodium channel gene by vasopressin and hyperosmolality. Hypertens Res 26: 626-634, 2003.
29. 2 receptor blockade and ACE inhibition. Cardiovasc Res 54: 51-57, 2002.
30. Oparil S, Chen YF, Meng QC, Jin HG, and Wyss JM. The neural basis of salt sensitivity in the rats: altered hypothalamic function. Am J Med Sci 295: 360-369, 1988.
31. Sánchez MM, Young LJ, Plotsky PM, and Insel TR. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 20: 4657-4668, 2000.
32. Sato T, Yoshimura R, Kawada T, Shishido T, Miyano H, Sugimachi M, and Sunagawa K. The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure. J Card Fail 4: 139-144, 1998.
33. Schunkert H, Tang SS, Litwin SE, Diamant D, Riegger G, Dzau VJ, and Ingelfinger JR. Regulation of intrarenal and circulating renin-angiotensin system in severe heart failure in the rat. Cardiovasc Res 27: 731-735, 1993.
34. Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, and Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99: 2694-2701, 1999.
35. 1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol 286: H1665-H1671, 2004.
36. Vahid-Ansari F and Leenen FHH. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol Heart Circ Physiol 275: H2140-H2146, 1998.
37. Victor RG, Thoren P, Morgan DA, and Mark AL. Differential control of adrenal and renal sympathetic nerve activity during hemorrhagic hypotension in rats. Circ Res 64: 689-694, 1989.
38. Wang H, Huang BS, Ganten D, and Leenen FHH. Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ Res 94: 843-849, 2004.
39. Wang H, Huang BS, and Leenen FHH. Brain sodium channels and ouabain-like compounds mediate central aldosterone-induced hypertension. Am J Physiol Heart Circ Physiol 285: H2516-H2523, 2003.
40. Wang H and Leenen FHH. Brain sodium channels mediate increases in brain "ouabain" and blood pressure in Dahl S rats. Hypertension 40: 96-100, 2002.
41. Zhang W, Huang BS, and Leenen FHH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol Heart Circ Physiol 276: H1608-H1616, 1999.
42. Zhang ZH, Francis J, Weiss RM, and Felder RB. The renin-angiotensin- aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 283: H423-H433, 2002.
43. Zhou ZH and Bubien JK. Nongenomic regulation of ENaC by aldosterone. Am J Physiol Cell Physiol 281: C1118 -C1130, 2001.
44. 1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 287: H1828-H1835, 2004.